Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1

NCT02090322 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity

Interventions

PROCEDURE: Injection of bevacizumab intravitreal (Avastin)

Sponsor

Universidad Autonoma de San Luis Potosí